Innovative Aquaculture Iterro Life Sciences has pioneered commercial-scale shallow-water indoor shrimp farming technology in the United States, creating opportunities to supply premium, traceable, and sustainable shrimp to markets seeking ethically and environmentally responsible seafood options.

Expanding Product Portfolio The company's production of shrimp, trū Chitosan, and trū Protein from shrimp material positions it well to collaborate with biotech, nutraceutical, and pet care companies interested in bio-based ingredients and sustainable raw materials.

Market Leadership Potential With its disruptive aquaculture technology and focus on quality and sustainability, Iterro has the potential to differentiate itself in the growing market for sustainable seafood and bio-products, appealing to environmentally conscious consumers and corporations.

Strategic Growth Opportunities Given its recent technological advancements and niche market focus, there are potential upsell and partnership opportunities with larger animal health, food production, and biotech firms looking to incorporate innovative, eco-friendly ingredients into their supply chains.

Financial Anchor Points With revenues estimated between $10 million and $25 million and a lean team of fewer than 50 employees, Iterro offers a scalable model that can attract joint ventures, investments, or contracts to accelerate growth in both domestic and international markets.